From Rx to OTC drugs: Challenges for marketing and market research

By Robert Dossin on May 05, 2011

In light of increasing patent expiration rates, a switch from Rx to OTC proves to be a successful counter-strategy against generic erosion. As a result, marketers face challenges entering a new competitive environment. Our Consumer Health team has valuable experience in bridging the knowledge gap between healthcare and consumer markets to facilitate your decision making process.

Continue Reading